2162-2531
Yes
MOL THER-NUCL ACIDS
0
159
UNITED STATES
http://www.nature.com/mtna/index.html
2区中科院分区
6.1影响因子
医学:研究与实验小学科
34/195JIF RANK
13223总被引频次
月期刊平台服务过的文章录用时间为1-3个月,依据20年经验,经月期刊专家预审通过后的文章,投稿通过率100%以上!
分子疗法-核酸是一种国际性的、开放获取的期刊,在核酸疗法治疗和/或纠正遗传和获得性疾病的广泛领域中,出版高质量的基础、翻译和临床研究。研究领域包括但不限于:基于核酸及其衍生物的治疗方法的开发、基于rna的治疗方法的载体开发和设计、基因修饰剂的应用,包括形成三聚体的寡核苷酸和酶(如锌指核酸酶)、临床前目标验证、安全性/有效性研究和临床试验。分子治疗-核酸2015影响因子为5.048。
http://mts-mtna.nature.com/cgi-bin/main.plex
Molecular Therapy — Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy — Nucleic Acids 2015 impact factor is 5.048.
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 | 2区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | MEDICINE, RESEARCH & EXPERIMENTAL | Q1 | 10.183 |
CiteScore | SJR | SNIP | 学科类别 | 分区 | 排名 | 百分位 |
12.90 | 1.852 | 1.421 | 大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery | Q1 | 10 / 154 |
93% |
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine | Q1 | 15 / 167 |
91% |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
10.183 | 43 | 99.71% | 89.53% | 开放 | 20 Weeks |